The Precision and Systems Biomedicine Laboratory aims to improve health outcomes by (1) developing better diagnostic tests for early detection of cancer, and (2) harnessing the power of omics technologies and computational systems biology methods to model molecular networks altered in disease and to predict therapeutic response.
The laboratory has a strong philosophy for inter-disciplinary collaboration, community and industry engagement to ensure translation of research outcomes.
Group Leader: Associate Professor Michelle Hill
- Dr Renee Richards, Laboratory and Research Manager
- Dr Ahmed Mohamed, Postdoctoral Research Fellow
- Dr Alok Shah, Postdoctoral Industry Research Fellow
- Dr Julie Webster, Postdoctoral Research Fellow
- Dr Mriga Dutt, Postdoctoral Research Fellow
- Jeffrey Molendijk, Research Assistant
- Harley Robinson, PhD Student
- Ruichao Zeng, PhD Student
- Annika Krueger, Visiting PhD Student
- Jennifer Nicol, Visiting PhD Student
- Patharee Oungsakul, Visiting PhD Student
- Development of lectin-immunoassays for new cancer biomarkers
- Role of the complement system and membrane attack complex in oesophageal adenocarcinoma
- Systems biology studies to reveal obesity-associated or disease-related lipid function in cancer, inflammatory bowel disease or neurodegeneration
- Protein and/or metabolite biomarkers for cancer diagnosis and prognosis, in various diseases including prostate, pancreatic, ovarian cancers, multiple myeloma, liver disease, inflammatory bowel disease.
- Obesity and immune-suppression in oesophageal adenocarcinoma
- Protein and/or metabolite biomarkers for cancer diagnosis and prognosis, in various cancers and chronic disease and neurodegeneration
- Systems biology studies to reveal obesity-associated or disease-related lipid function in cancer, chronic disease or neurodegeneration
If you wish to apply for QIMR Berghofer's student program,
click here for more information.